Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC265

1-(2,2-díflúoró-2H-1,3-bensódíoxól-5-ýl)-N-(1-[(2R]-2,3-díhýdroxýprópýl]-6-flúoró-2-(1-hýdroxý-2-metýlprópan-2-ýl)-1H-indól-5-ýl)sýklóprópan-1-karboxamíð

  • Status:
    Veitt
  • Application date:
    16.4.2019
  • Application published:
    15.5.2019
  • Grant published:
    15.9.2020
  • Max expiry date:
    5.11.2033
  • Medicine name:
    Symkevi
  • Medicine for children:
    No

Timeline

Today
16.4.2019Application
15.5.2019Publication
15.9.2020Registration
5.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1306/001
  • Date:
    13.11.2018
  • Foreign authorization number:
    EU/1/18/1306
  • Date:
    31.10.2018

Owner

  • Name:
    Vertex Pharmaceuticals Incorporated
  • Address:
    50 Northern Avenue, Boston US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents